Invitrogen has appointed Kelli Richard to vice president of finance and chief accounting officer. Before joining Invitrogen in 2005, Richard spent 14 years in accounting and financial reporting, and was vice president of accounting and reporting and a principal accounting officer at Gateway.
Oxford Genome Sciences has appointed Mike Gresser to its scientific advisory board, the company said last week. Gresser is currently a visiting scholar at the Molecular Biology Institute at the University of California, Los Angeles.
He served before that as executive director of biochemistry and molecular biology at the Merck Frost Center for Therapeutic Research in Quebec.
Transgenomic said last week Roland Santoni has resigned from his positions on the company’s board of directors, compensation committee, and audit committee. The company has appointed Rodney Markin to fill the vacancy.
Santoni had served on the company’s board since 2000.
Markin currently is a professor of pathology, microbiology and surgery and senior associate dean for clinical affairs at the College of Medicine at the University of Nebraska. He also is chairman, president and CEO of UNMC, the University of Nebraska’s medical practice.
Bio-Rad Laboratories said that it has appointed Louis Drapeau to its board of directors, bringing the company back in line with American Stock Exchange listing rules governing the number of directors who must sit on the board’s audit committee.
The company was left with an empty seat on that committee when board member Philip Padou died late in 2006.
Drapeau will face official election to the post at a board meeting in late April.